We also find that those who developed PF have a more rapid increase in fatigue early during IFN-α treatment, as well as higher IL-10 levels before treatment, and IL-10 and IL-6 levels early on during IFN-α treatment – that is, more than one year before the PF phenotype is established. This evidence concerns the gene IL6 and pemphigus foliaceus.